☰

Dhong H. Lee, Ph.D. - Publications

Affiliations: 
2010 University of California, Los Angeles, Los Angeles, CA 
Area:
Biomedical Engineering, Molecular Biology, Genetics
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Marijon H, Gery S, Chang H, Landesman Y, Shacham S, Lee DH, de Gramont A, Koeffler HP. Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status. Oncotarget. 12: 1749-1762. PMID 34504648 DOI: 10.18632/oncotarget.28047  0.432
2018 Marijon H, Lee DH, Ding L, Sun H, Gery S, de Gramont A, Koeffler HP. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 99: 543-551. PMID 29902865 DOI: 10.1016/J.Biopha.2018.01.045  0.439
2017 Xie J, Lin D, Lee DH, Akunowicz J, Hansen M, Miller C, Sanada M, Kato M, Akagi T, Kawamata N, Ogawa S, Koeffler HP. Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma. International Journal of Oncology. PMID 28197627 DOI: 10.3892/Ijo.2017.3864  0.361
2015 Kanojia D, Nagata Y, Garg M, Lee DH, Sato A, Yoshida K, Sato Y, Sanada M, M T A, Bartenhagen C, Klein HU, Doan NB, Said JW, Mohith S, Gunasekar S, et al. Genomic landscape of liposarcoma. Oncotarget. PMID 26643872 DOI: 10.18632/Oncotarget.6464  0.468
2015 Lee DH, Forscher C, Di Vizio D, Koeffler HP. Induction of p53-independent apoptosis by ectopic expression of HOXA5 in human liposarcomas. Scientific Reports. 5: 12580. PMID 26219418 DOI: 10.1038/Srep12580  0.43
2015 Lee DH, Qi J, Bradner JE, Said JW, Doan NB, Forscher C, Yang H, Koeffler HP. Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. International Journal of Cancer. Journal International Du Cancer. 136: 2055-64. PMID 25307878 DOI: 10.1002/Ijc.29269  0.477
2015 Kanojia D, Garg M, Nagata Y, Lee DH, Klein H, Bartenhagen C, T AM, Doan NB, Said JW, Yang H, Forscher C, Dugas M, Ogawa S, Koeffler HP. Abstract A2-20: Integrative study of genomic alterations in liposarcoma Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-20  0.458
2014 Chien W, Lee DH, Zheng Y, Wuensche P, Alvarez R, Wen DL, Aribi AM, Thean SM, Doan NB, Said JW, Koeffler HP. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo. Molecular Carcinogenesis. 53: 722-35. PMID 23475695 DOI: 10.1002/Mc.22024  0.487
2013 Lee DH, Amanat S, Goff C, Weiss LM, Said JW, Doan NB, Sato-Otsubo A, Ogawa S, Forscher C, Koeffler HP. Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival. Oncogenesis. 2: e47. PMID 23689287 DOI: 10.1038/oncsis.2013.10  0.354
2013 Aribi A, Gery S, Lee DH, Thoennissen NH, Thoennissen GB, Alvarez R, Ho Q, Lee K, Doan NB, Chan KT, Toh M, Said JW, Koeffler HP. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. International Journal of Cancer. Journal International Du Cancer. 132: 2730-7. PMID 23165325 DOI: 10.1002/Ijc.27950  0.464
2011 Lee DH, Thoennissen NH, Goff C, Iwanski GB, Forscher C, Doan NB, Said JW, Koeffler HP. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Letters. 306: 161-70. PMID 21440986 DOI: 10.1016/J.Canlet.2011.03.001  0.451
2010 Iwanski GB, Lee DH, En-Gal S, Doan NB, Castor B, Vogt M, Toh M, Bokemeyer C, Said JW, Thoennissen NH, Koeffler HP. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. British Journal of Pharmacology. 160: 998-1007. PMID 20590594 DOI: 10.1111/J.1476-5381.2010.00741.X  0.471
2010 Lee DH, Iwanski GB, Thoennissen NH. Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment The Scientific World Journal. 10: 413-418. PMID 20209387 DOI: 10.1100/Tsw.2010.44  0.342
2010 Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, Koren-Michowitz M, Kato M, Sanada M, Shih LY, Nagler A, Raynaud SD, Müller-Tidow C, et al. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood. 115: 2882-90. PMID 20068225 DOI: 10.1182/Blood-2009-07-235119  0.322
2010 Lee DH, Thoennissen NH, Goff CB, Iwanski GB, Doan NB, Toh M, Chan T, Said JW, Koeffler HP. Abstract 5396: Synergistic effect of cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma Cancer Research. 70: 5396-5396. DOI: 10.1158/1538-7445.Am10-5396  0.474
Show low-probability matches.